Download PDF
Synthesis 2011(18): 3027-3031  
DOI: 10.1055/s-0030-1260125
PAPER
© Georg Thieme Verlag Stuttgart ˙ New York

The Aldol Addition of Readily Enolizable 1,3-Dicarbonyl Compounds to 2-Cyanobenzaldehyde in the Synthesis of Novel 3-Substituted Isoindolinones

Vijaykumar Moreb, Antonia Di Molab, Milena Perilloa, Paolo De Caprariisb, Rosanna Filosab, Antonella Pedutob, Antonio Massa*a
Dipartimento di Chimica e Biologia, Università di Salerno, Via Ponte Don Melillo, 84084 Fisciano (SA), Italy
Fax: +39(89)969603; e-Mail: amassa@unisa.it;
Dipartimento di Scienze Farmaceutiche, Università di Salerno, Via Ponte Don Melillo, 84084 Fisciano (SA), Italy
Further Information

Publication History

Received 3 May 2011
Publication Date:
01 August 2011 (online)

    Permissions and Reprints All articles of this category

Abstract

The aldol addition of readily enolizable 1,3-dicarbonyl compounds to 2-cyanobenzaldehyde in the presence of a tertiary amine led to a series of new 3-substituted isoindolinones. Despite the instability of the related aldols, this synthesis was possible because of the intramolecular trapping of the adducts with the cyano group due to a tandem process of cyclization and rearrangement. Simple decarboxylation of some derivatives gave access to very useful compounds.

Key words

isoindolinones - aldol addition - enolizable 1,3-dicarbonyl compounds - 2-cyanobenzaldehyde

    References

  • For antihypertensive activity, see:
  • 1a Ferland J.-M. Demerson CA. Humber LG. Can. J. Chem.  1985,  63:  361 
    Google Scholar
  • For antipsychotic activity, see:
  • 1b Linden M. Hadler D. Hofmann S. Hum. Psychopharmacol.  1997,  12:  445 
    Google Scholar
  • 1c Zhuang Z.-P. Kung M.-P. Mu M. Kung HF. J. Med. Chem.  1998,  41:  157 
    Google Scholar
  • 1d Norman MH. Minick DJ. Rigdon GC. J. Med. Chem.  1996,  39:  149 
    Google Scholar
  • For anesthesic activity, see:
  • 1e Marushiiri A. inventors; JP  59,046,268.  ; Chem. Abstr. 1984, 101, 54922
    Google Scholar
  • For antiulcer activity, see:
  • 1f Lippmann W. inventors; US  4,267,189.  ; Chem. Abstr. 1981, 95, 61988
    Google Scholar
  • For antiviral activity, see:
  • 1g Govindachari TR. Ravindranath KR. Viswanathan N. J. Chem. Soc., Perkin Trans. 1  1974,  1215 
    Google Scholar
  • 1h Pendrak I. Barney S. Wittrock R. Lambert DM. Kingsbury WD. J. Org. Chem.  1994,  59:  2623 
    Google Scholar
  • 1i De Clercq E. J. Med. Chem.  1995,  38:  2491 
    Google Scholar
  • For antileukemic activity, see:
  • 1j Taylor EC. Zhou P. Jenning LD. Mao Z. Hu B. Jun J.-G. Tetrahedron Lett.  1997,  38:  521 
    Google Scholar
  • For other interesting biological properties see also:
  • 1k Rang HP. Dale MM. Ritter JM. In Pharmacology   3rd ed.:  Churchill-Livingstone; London: 1995. 
    Google Scholar
  • 1l Takahashi I. Kawakami T. Hirano E. Yokota H. Kitajima H. Synlett  1996,  353 
    Google Scholar
  • 1m Anzini M. Cappelli A. Vomero S. Giorgi G. Langer T. Bruni G. Romeo MR. Basile AS. J. Med. Chem.  1996,  36:  4275 
    Google Scholar
  • 2a Kato Y. Takemoto M. Achiwa K. Chem. Pharm. Bull.  1993,  41:  2003 
    Google Scholar
  • 2b Holzgrabe U. Bender W. Botero Cid HM. Staudt M. Pick R. Pfletschinger C. Balatková E. Tränkle C. Mohr K. Pharm. Helv. Acta  2000,  74:  149 
    Google Scholar
  • 2c Botero Cid HM. Tränkle C. Baumann K. Pick R. Mies-Klomfass E. Kostenis E. Mohr K. Holzgrabe U.
    J. Med. Chem.  2000,  43:  2155 
    Google Scholar
  • 2d Mertens A. Zilch H. König B. Schäfer W. Poll T. Kampe W. Seidel H. Leser U. Leinert H. J. Med. Chem.  1993,  36:  2526 
    Google Scholar
  • 2e Mager PP. Drug Des. Discovery  1996,  14:  241 
    Google Scholar
  • 2f Kundu NG. Khan MW. Tetrahedron  2000,  56:  4777 
    Google Scholar
  • 2g Kreher RP. Hennige H. Konrad M. Uhrig J. Clemens A. Z. Naturforsch., B: Chem. Sci.  1991,  46:  809 
    Google Scholar
  • 2h Othman M. Pigeon P. Decroix B. Tetrahedron  1997,  53:  2495 
    Google Scholar
  • 3a Belliotti TR. Brink WA. Kestern SR. Rubin JR. Wistrow DJ. Zoski KT. Whetzel SZ. Corbin AE. Pugsley TA. Heffner TG. Wise LD. Bioorg. Med. Chem. Lett.  1998,  8:  1499 
    Google Scholar
  • 3b Nageshwar Rao I. Prabhakaran EN. Kumar Das S. Iqbal J. J. Org. Chem.  2003,  68:  4079 
    Google Scholar
  • 3c Lamblin M. Couture A. Deniau E. Grandclaudon P. Tetrahedron: Asymmetry  2008,  19:  111 
    Google Scholar
  • 3d Zhu C. Falck JR. Org. Lett.  2011,  13:  1214 
    Google Scholar
  • 3e Enders D. Braig V. Raabe G. Can. J. Chem.  2001,  79:  1528 
    Google Scholar
  • 4a Angelin M. Rahm M. Fischer A. Brinck T. Ramstrom O. J. Org. Chem.  2010,  75:  5882 
    Google Scholar
  • 4b Angelin M. Vongvilai P. Fischer A. Ramstrom O. Chem. Commun.  2008,  768 
    Google Scholar
  • 4c Angelin M. Fischer A. Ramstrom O. J. Org. Chem.  2008,  73:  3593 
    Google Scholar
  • 5a Massa A. Scettri A. Filosa R. Capozzolo L. Tetrahedron Lett.  2009,  50:  7318 
    Google Scholar
  • 5b Massa A. Roscigno A. De Caprariis P. Filosa R. Di Mola A. Adv. Synth. Catal.  2010,  352:  3348 
    Google Scholar
  • 6 Krapcho AP. Weimaster JF. Eldridge JM. Jahngen EGE. Lovey AJ. Stephens WP. J. Org. Chem.  1978,  43:  138 
    CrossrefGoogle Scholar
  • 7 Kobayashi K. Matsumoto K. Konishi H. Heterocycles  2011,  83:  99 
    CrossrefGoogle Scholar